Alhamlan F S, Majumder M S, Brownstein J S, Hawkins J, Al-Abdely H M, Alzahrani A, Obaid D A, Al-Ahdal M N, BinSaeed A
Department of Infection and Immunity, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
BMJ Open. 2017 Jan 12;7(1):e011865. doi: 10.1136/bmjopen-2016-011865.
As of 1 November 2015, the Saudi Ministry of Health had reported 1273 cases of Middle East respiratory syndrome (MERS); among these cases, which included 9 outbreaks at several hospitals, 717 (56%) patients recovered, 14 (1%) remain hospitalised and 543 (43%) died. This study aimed to determine the epidemiological, demographic and clinical characteristics that distinguished cases of MERS contracted during outbreaks from those contracted sporadically (ie, non-outbreak) between 2012 and 2015 in Saudi Arabia.
Data from the Saudi Ministry of Health of confirmed outbreak and non-outbreak cases of MERS coronavirus (CoV) infections from September 2012 through October 2015 were abstracted and analysed. Univariate and descriptive statistical analyses were conducted, and the time between disease onset and confirmation, onset and notification and onset and death were examined.
A total of 1250 patients (aged 0-109 years; mean, 50.825 years) were reported infected with MERS-CoV. Approximately two-thirds of all MERS cases were diagnosed in men for outbreak and non-outbreak cases. Healthcare workers comprised 22% of all MERS cases for outbreak and non-outbreak cases. Nosocomial infections comprised one-third of all Saudi MERS cases; however, nosocomial infections occurred more frequently in outbreak than non-outbreak cases (p<0.001). Patients contracting MERS during an outbreak were significantly more likely to die of MERS (p<0.001).
To date, nosocomial infections have fuelled MERS outbreaks. Given that the Kingdom of Saudi Arabia is a worldwide religious travel destination, localised outbreaks may have massive global implications and effective outbreak preventive measures are needed.
截至2015年11月1日,沙特阿拉伯卫生部报告了1273例中东呼吸综合征(MERS)病例;在这些病例中,包括几家医院发生的9起疫情,717例(56%)患者康复,14例(1%)仍住院治疗,543例(43%)死亡。本研究旨在确定2012年至2015年期间沙特阿拉伯在疫情期间感染的MERS病例与散发性(即非疫情期间)感染的病例在流行病学、人口统计学和临床特征上的差异。
提取并分析了沙特阿拉伯卫生部2012年9月至2015年10月确诊的MERS冠状病毒(CoV)感染疫情病例和非疫情病例的数据。进行了单变量和描述性统计分析,并检查了疾病发病与确诊、发病与通报以及发病与死亡之间的时间。
共报告1250例患者(年龄0至109岁;平均50.825岁)感染了MERS-CoV。在疫情病例和非疫情病例中,所有MERS病例中约三分之二为男性确诊。医护人员占所有MERS病例的22%,包括疫情病例和非疫情病例。医院感染占沙特所有MERS病例的三分之一;然而,医院感染在疫情期间比非疫情期间更频繁发生(p<0.001)。在疫情期间感染MERS的患者死于MERS的可能性显著更高(p<0.001)。
迄今为止,医院感染助长了MERS疫情。鉴于沙特阿拉伯王国是全球宗教旅游目的地,局部疫情可能产生巨大的全球影响,因此需要有效的疫情预防措施。